Cargando…
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine
OBJECTIVE: The main objective of this pilot study was to investigate the safety of administering onabotulinumtoxinA towards the sphenopalatine ganglion in 10 patients with intractable chronic migraine with an open, uncontrolled design. We also collected efficacy data to provide an indication as to w...
Autores principales: | Bratbak, Daniel Fossum, Nordgård, Ståle, Stovner, Lars Jacob, Linde, Mattias, Dodick, David W, Aschehoug, Irina, Folvik, Mari, Tronvik, Erling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394468/ https://www.ncbi.nlm.nih.gov/pubmed/27154997 http://dx.doi.org/10.1177/0333102416648328 |
Ejemplares similares
-
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache
por: Bratbak, Daniel Fossum, et al.
Publicado: (2015) -
Long‐Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion – An Observational Study
por: Aschehoug, Irina, et al.
Publicado: (2018) -
Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia
por: Crespi, Joan, et al.
Publicado: (2019) -
EHMTI-0191. A novel approach for the treatment of cluster headache – onabotulinumtoxina block of the sphenopalatine ganglion
por: Bratbak, D, et al.
Publicado: (2014) -
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine
por: Stovner, Lars Jacob, et al.
Publicado: (2022)